NCT01622231View on ClinicalTrials.gov

Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Rhinitis
Interventions
DRUG

Fluticasone furoate

55 mcg/day, intranasal, 12 weeks

Trial Locations (6)

272-0143

GSK Investigational Site, Chiba

277-0882

GSK Investigational Site, Chiba

501-3247

GSK Investigational Site, Gifu

355-0062

GSK Investigational Site, Saitama

160-0017

GSK Investigational Site, Tokyo

170-0005

GSK Investigational Site, Tokyo

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01622231 - Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis | Biotech Hunter | Biotech Hunter